[The impact of early developmental impairment of the receptor-dependent glucocorticoid action on the pituitary adrenal axis activity and behavior of male rats].
Pivina
S G
SG
Akulova
V K
VK
Ordian
N E
NE
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000494:pharmacology; D001007:Anxiety / Q000139:chemically induced / Q000378:metabolism; D001522:Behavior, Animal / Q000187:drug effects*; D001921:Brain / Q000254:growth & development / Q000378:metabolism; D005938:Glucocorticoids / Q000009:adverse effects* / Q000494:pharmacology; D006727:Hormone Antagonists / Q000009:adverse effects* / Q000494:pharmacology; D006854:Hydrocortisone / Q000009:adverse effects* / Q000494:pharmacology; D008297:Male; D015735:Mifepristone / Q000009:adverse effects* / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects; D010913:Pituitary-Adrenal System / Q000254:growth & development* / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D011965:Receptors, Glucocorticoid / Q000037:antagonists & inhibitors / Q000378:metabolism
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D006727:Hormone Antagonists; D011965:Receptors, Glucocorticoid; D015735:Mifepristone; D006854:Hydrocortisone